Skip to content
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Resources
2024 Saving Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
Digital Campaigns
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
Resources
2024 Saving Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
Digital Campaigns
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
Advocacy
Issues Overview
State Advocacy
GDUFA/BsUFA User Fees
Action Center
Events
Access! 2025
GRx+Biosims 2025
Press Releases
JOIN
Advocacy
Issues Overview
State Advocacy
GDUFA/BsUFA User Fees
Action Center
Events
Access! 2025
GRx+Biosims 2025
Press Releases
JOIN
Home
Resources
Blog
Blog
Blog
December 11, 2024
AAM
Congress Should Pass Legislation to End the Shenanigans That Allow Brand-Name Drug Manufacturers to Delay Generic Competition and Charge Higher Prices for Longer Periods
Blog
November 8, 2024
AAM
GRx+Biosims 2024 Conference Recap
Blog
September 10, 2024
AAM
Want to Save Patients Money on Medicine? No Need to Reinvent the Wheel
Blog
September 5, 2024
AAM
2024 Savings Report
Blog
June 25, 2024
AAM
Senate Finance Committee Bill Addressing Drug Shortages Would Provide Long Overdue Relief from Penalties Hurting Generic Drug Market
Blog
April 16, 2024
AAM
Seniors Pay More for Generic Medicines Every Year While Prices Continue to Fall. Why?
Blog
February 22, 2024
AAM
Access! 2024 – Charting a Sustainable Path for Generics and Biosimilars
Blog
October 20, 2023
AAM
2023 Report
Blog
October 18, 2023
AAM
GRx+Biosims 2023 Conference Recap
Blog
September 13, 2023
AAM
Member Spotlight: Biocon Biologics
Blog
August 24, 2023
AAM
2020 Report
Blog
August 24, 2023
AAM
2019 Generic Drug and Biosimilars Access & Savings in the U.S. Report
Load More
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Resources
2024 Saving Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
Digital Campaigns
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
Advocacy
Issues Overview
State Advocacy
GDUFA/BsUFA User Fees
Action Center
Events
Access! 2025
GRx+Biosims 2025
Press Releases
JOIN
